Optimising rare tumour risk syndromes care: clinical insights and the PREVENTABLE socioeconomic framework
Sara B. Pereira, Liliana Sousa, Ricardo Amorim, Luzia Garrido et autres
1 citationEuropean Journal of Human Genetics
Silvana Lobo
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
16Publications signalées
143Citations signalées
2Affiliations récentes
Institutions déclarées
Domaines associés
Epigenetics and DNA MethylationWnt/β-catenin signaling in development and cancerCancer-related gene regulationGenomics and Chromatin DynamicsBRCA gene mutations in cancer
Publications récentes
Hereditary diffuse gastric cancer spectrum associated with germline CTNNA1 loss of function revealed by clinical and molecular data from 351 carrier families and over 37 000 non-carrier controls
Silvana Lobo, Alexandre Dias, Marta Ferreira, André Pinto-Oliveira et autres
8 citationsGut
A protocol for karyotyping and genetic editing of induced pluripotent stem cells with homology-directed repair mediated CRISPR/Cas9
Silvana Lobo, Rita Barbosa‐Matos, Sofia Dória, Ana Maria de Brito et autres
5 citationsBiology Methods and Protocols
EPIDEMIOLOGY OF PROSTATE CANCER IN PARÁ
Quenia dos Santos, Silvana Lobo, R. H. L. MACAMBIRA
0 citations
Combined Analysis of Chromatin Accessibility, Promoter Interactions and Whole Genome Sequencing Disclosed the Missing Heritability in Gastric Cancer
Celina São José, Marta S. Ferreira, Lílian Córdova, Ana Pedro et autres
0 citationsSSRN Electronic Journal
Combined analysis of chromatin accessibility, promoter interactions and whole genome sequencing solved the missing heritability in gastric cancer
Celina São José, Marta Ferreira, Augusto Q. Pedro, Janine Senz et autres
0 citationsmedRxiv
18P The role of CTNNA1 truncating variants in hereditary diffuse gastric cancer (HDGC)
Silvana Lobo, Adriano Basso Dias, Marta Ferreira, J. Herrera-Mullar et autres
1 citationAnnals of Oncology
Efficacité de la 20-hydroxyecdysone orale (20E) chez les adultes atteints de COVID-19 sévère : Résultats d'un essai de phase 2/3 randomisé et contrôlé par placebo
Valérie Pourcher, Alice Desclaux, Edward V. Nunes, A. Amin et autres
0 citationsMédecine et Maladies Infectieuses Formation
CTNNA1, a New HDGC Gene: Inactivating Mechanisms and Driven Phenotypes
Silvana Lobo, Paulo S. Pereira, Patrick R. Benusiglio, Carla Oliveíra
1 citation
Genotype-first approach to identify associations between CDH1 germline variants and cancer phenotypes: a multicentre study by the European Reference Network on Genetic Tumour Risk Syndromes
José Garcia‐Pelaez, Rita Barbosa‐Matos, Silvana Lobo, Alexandre Dias et autres
40 citationsThe Lancet Oncology
First estimates of diffuse gastric cancer risks for carriers of CTNNA1 germline pathogenic variants
Marie Coudert, Youenn Drouet, Hélène Delhomelle, Magali Svrcek et autres
23 citationsJournal of Medical Genetics
Cancer predisposition and germline CTNNA1 variants
Silvana Lobo, Patrick R. Benusiglio, Florence Coulet, Lise Boussemart et autres
47 citationsEuropean Journal of Medical Genetics
BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, ROR et la Banque mondiale, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune donnée externe enregistrée en base. Sources et limites.